RadNet incorporates artificial intelligence (AI) into low-dose computed tomography (LDCT) screening for lung cancer – advancing lung cancer detection at its earliest stages. LDCT screening for lung ...

RadNet’s first quarter results were defined by the interplay of weather-related disruptions and ongoing investment in ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

RadNet has incorporated artificial intelligence into low-dose computed tomography (LDCT) screening for lung cancer — ...

Equity Insider News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, June 17, 2025 /PRNewswire/ -- Venture Capital continues to flow in bunches into the AI in healthcare ...

(NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services, today announced that it has entered into Incremental ...

Barclays analyst Andrew Mok CFA maintained a Buy rating on Radnet (RDNT – Research Report) today and set a price target of $60.00. The company’s shares closed last Friday at $ ...

RadNet, Inc. (NASDAQ:RDNT) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 29 hedge fund portfolios held RadNet, Inc. (NASDAQ:RDNT) at the end of the fourth ...

RadNet's stock performance has been lackluster, with only an 8.8% increase over the past year, currently trading at $50 per share. Click to read why RDNT is a Hold.

LOS ANGELES, Sept. 03, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned ...